This week, we will discuss the RaDaR study. Does rare mean kidney failure occurs rarely? What are rare diseases? Do we see them in children more than adults? All this and more!
Heart-burn and Kidney Churn
FLOWing with the SemagluTIDE
The KDIGO 2024 CKD Guidelines: part 2
The KDIGO CKD 2024 Guidelines Part 1: Evaluation and Risk Stratification
Shedding Light on the Dense Matter of C3 Glomerulopathy
Healing, Hype, or Harm: The NefIgArd trial
PRAECISely Predicting Preeclampsia
The Worldwide Shadow of Kidney Disease
The PROTECT-V platform - RENALISM no more?
Dialysis dreams and sleepless realities: the SLEEP-HD trial
Hungry Like The Wolf for New Lupus Nephritis Guidance
Is Eculizumab a good Complement in STEC-HUS?
Two’s Company but Three maybe the Winner? Aldosterone Synthase Inhibition added to RASi + Flozin
ACE-ing the SPACE Trial: traversing the seas of RAS inhibition in non-cardiac surgery
Zibotentan and Flozins: Climbing to the ZENITH of nephroprotection?
Optimizing “Sparse” Treatments for FSGS
BEATing Calciphylaxis with an Adaptive Platform design
Unlocking the door to living kidney donor paradise?
This week, nephrologists hope they found the key to no-dialysis-land, where kindness and detailed, multistep interventions make the path to kidney transplant much easier. This was foreseen in our Freely Filtered episode and disputed during #KidneyWK 2023 late-breaking clinical trials session. Still, when it comes to RCTs’ results, will it be Deja Vu or a happy ending?
